Skip to content

The association study of genetic polymorphism on the sevoflurane clinical response

The association study of genetic polymorphism on the sevoflurane clinical response

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017368
Enrollment
Unknown
Registered
2018-07-26
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic surgery patients

Interventions

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) age over 18 years old, less than 45 years old, body mass index 18 - 28kg/m2; (2) ASA I-II level; (3) general anesthesia, hysteroscopy.

Exclusion criteria

Exclusion criteria: (1) suspect or confirm that there is a history of alcohol / drug abuse in 1 years; (2) pregnancy, fever, electrolyte disturbance, hyperthyroidism, and severe anemia; (3) severe cardiopulmonary history, abnormal liver and kidney function (AST, ALT normal upper limit 2 times higher; Scr normal upper limit 1.2 times higher); (4) inhaled anesthetics were accepted in the last three months.

Design outcomes

Primary

MeasureTime frame
MOAA/S;Gene;

Countries

China

Contacts

Public ContactOuyang Wen

The Third Xiangya Hospital of Central South University

ouyangwen133@vip.sina.com+86 18975183003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026